Treatment of pelvic inflammatory disease with combined piperacillin and minocycline therapy.
Pelvic inflammatory disease (PID) has its aetiopathogenesis especially in anaerobic microorganisms and it is considered that 15% of patients with PID do not respond to initial treatment, 20% have at least one recurrence and 18% become sterile. Forty-six patients aged between 18 and 45 treated as out-patients with the association piperacillin-minocycline have been considered. These patients were monitored up to 5 weeks from the start of therapy following standard evaluation criteria and it is held that this therapy is effective and indicated as a first approach.
Surico
N
N
Cattedra B-Istituto di Ginecologia ed Ostetricia dell'Università di Torino.
Tavassoli
K
K
D000293:Adolescent; D000328:Adult; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use*; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000382:microbiology; D010878:Piperacillin / Q000627:therapeutic use*
D008911:Minocycline; D010878:Piperacillin